References
- International Agency for research on cancer. World Health
Organization. Global
cancer observatory Accessed 14 Sep 2017.
- Ly M, Valent A, Diallo G, Penault-Lorca F, Dumke K, Marty V et al. Gene copy number variations in breast cancer of Sub-Saharan African women. The Breast. 2013 Jun;22(3):295-300. PubMed | Google Scholar
- Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008 Aug;9(8):730-56. PubMed | Google Scholar
- Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J et al. Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer. J Clin Oncol. 2009 Sep 20;27(27):4515-21. PubMed | Google Scholar
- Dem A, Traoré B, Dieng MM, Diop PS, Ouajdi T, Lalami MT et al. Gynaecological and breast cancers at the Dakar Cancer Institute. Sante. Sante. 2008 Jan-Mar;18(1):25-9. PubMed | Google Scholar
- Proctor E, Kidwell KM, Jiagge E, Bensenhaver J,
Awuah B, Gyan K et al. Characterizing breast cancer in a population
with increased prevalence of triple-negative breast
cancer: androgen receptor and ALDH1 expression in Ghanaian
Women. Ann Surg Oncol. 2015
Nov;22(12):3831-5. PubMed | Google
Scholar
- Gueye M, Gueye SMK, Diallo M, Thiam O, Mbodji A,
Diouf A et al. Sociodemographic factors associated with delays
in breast cancer. Open J Obstet Gynecol. 2017;07:455. Google
Scholar
- Miguel F, Lopes LV, Ferreira E, Ribas E, Pelaez AF, Leal C et al. Breast cancer in Angola, molecular subtypes: a first glance. Ecancermedicalscience. 2017 Aug 30;11:763. PubMed | Google Scholar
- Effi AB, Aman NA, Koui BS, Koffi KD, Traore ZC, Kouyate M. Breast Cancer Molecular Subtypes Defined by ER/PR and HER2 Status: association with Clinicopathologic Parameters in Ivorian Patients. Asian Pac J Cancer Prev. 2016;17(4):1973-8. PubMed | Google Scholar
- Hoque MO, Feng Q, Toure P, Dem A, Critchlow CW, Hawes SE et al. Detection of Aberrant Methylation of Four Genes in Plasma DNA for the Detection of Breast Cancer. J Clin Oncol. 2006 Sep 10;24(26):4262-9. PubMed | Google Scholar
- Hulsen T, de Vlieg J, Alkema W. BioVenn: a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics. 2008;9:488. PubMed | Google Scholar
- Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 2002 Sep;41(3A):151-2, discussion 152-3. PubMed | Google Scholar
- Fitzgibbons PL, Murphy DA, Hammond MEH, Allred DC, Valenstein PN. Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays. Arch Pathol Lab Med. 2010 Jun;134(6):930-5. PubMed | Google Scholar
- Grimm EE, Schmidt RA, Swanson PE, Dintzis SM, Allison KH. Achieving 95% Cross-Methodological Concordance in HER2 Testing: Causes and Implications of Discordant Cases. Am J Clin Pathol. Am J Clin Pathol. 2010 Aug;134(2):284-92. PubMed | Google Scholar
- Allison KH, Dintzis SM, Schmidt RA. Frequency of HER2 heterogeneity by fluorescence in situ hybridization according to CAP expert panel recommendations: time for a new look at how to report heterogeneity. Am J Clin Pathol. 2011 Dec;136(6):864-71. PubMed | Google Scholar
- Adeloye D, Sowunmi OY, Jacobs W, David RA, Adeosun AA, Amuta AO et al. Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis. J Glob Health. J Glob Health. 2018 Jun;8(1):010419. PubMed
- Silverstein A, Sood R, Costas-Chavarri A. Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine. Int J Breast Cancer. 2016;2016:4792865. PubMed | Google Scholar
- Bray F, Ren J-S, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013 Mar 1;132(5):1133-45. PubMed | Google Scholar
- Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K et al. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA. 2006 Jun 7;295(21):2492-502. PubMed | Google Scholar
- Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer. 2001;85(1):69. PubMed | Google Scholar
- Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. Pan Afr Med J. 2014;17:249. PubMed | Google Scholar
- Popoola AO, Ogunleye OO, Ibrahim NA, Omodele FO,
Igwilo AI. Five year survival of patients with breast
cancer at the Lagos State University Teaching Hospital,
Nigeria. Online J Med Med Sci Res.
2012;1:24-31.
- Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. JA-MA Oncol. 2017;3(12):1654-62. PubMed | Google Scholar
- Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235(4785):177-82. PubMed | Google Scholar
- Linnenbringer E, Gehlert S, Geronimus AT. Black-white
disparities in breast cancer subtype: the intersection
of socially patterned stress and genetic expression.
AIMS Public Health. 2017;4(5):526-56. PubMed | Google
Scholar